Next Article in Journal
DTBV: A Deep Transfer-Based Bone Cancer Diagnosis System Using VGG16 Feature Extraction
Next Article in Special Issue
Organ-Specific Positron Emission Tomography Scanners for Breast Imaging: Comparison between the Performances of Prior and Novel Models
Previous Article in Journal
Differentiating Multiple Myeloma and Osteolytic Bone Metastases on Contrast-Enhanced Computed Tomography Scans: The Feasibility of Radiomics Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI

1
Department of Radiology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan
2
Department of Radiological Technology, Faculty of Medical Sciences, Kyoto College of Medical Science, Kyoto 622-0041, Japan
3
Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan
4
Biomedical Imaging Research Center, University of Fukui, Fukui 910-1193, Japan
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(4), 756; https://doi.org/10.3390/diagnostics13040756
Submission received: 20 January 2023 / Revised: 7 February 2023 / Accepted: 14 February 2023 / Published: 16 February 2023
(This article belongs to the Special Issue Advances in Multimodality Molecular Imaging-Volume 2)

Abstract

:
We investigated the relationship between MRI-arterial spin labeling (ASL) parameters and PET-cerebral blood flow (CBF)/cerebrovascular reactivity (CVR) simultaneously obtained by PET/MRI in Moyamoya disease. Twelve patients underwent 15O-water PET/MRI with the acetazolamide (ACZ) challenge test. PET-CBF and PET-CVR were measured using 15O-water PET. Pseudo-continuous ASL obtained the robust arterial transit time (ATT) and ASL-CBF estimation. ASL parameters were compared with PET-CBF and PET-CVR. Before ACZ loading, absolute and relative ASL-CBF were significantly correlated with absolute and relative PET-CBF (r = 0.44, p < 0.0001, and r = 0.55, p < 0.0001, respectively). After ACZ loading, absolute and relative ASL-CBF were significantly correlated with absolute and relative PET-CBF (r = 0.56, p < 0.001, and r = 0.75, p < 0.0001, respectively), and ΔASL-CBF was significantly correlated with ΔPET-CBF (r = 0.65, p < 0.0001). Baseline ASL-ATT had strong negative correlations with ΔPET-CBF and PET-CVR (r = −0.72, p < 0.0001, and r = −0.66, p < 0.0001, respectively). Baseline ASL-ATT of MCA territories with CVR <30% (1546 ± 79 ms) was significantly higher than that with CVR > 30% (898 ± 197 ms). ASL-ATT ratio of MCA territories with CVR < 30% (94.0 ± 10.5%) was significantly higher than that with CVR > 30% (81.4 ± 11.3%). ATT correction using multiple postlabeling delays increased the accuracy of ASL-CBF quantitation. Baseline ASL-ATT is a hemodynamic parameter and may represent an efficient alternative to PET-CVR.

1. Introduction

Positron emission tomography (PET) is a well-established method for hemodynamic evaluation of cerebral blood flow (CBF) and oxygen metabolism such as oxygen extraction fraction (OEF) in steno-occlusive cerebrovascular diseases (CVDs) [1,2]. An elevated OEF determined by PET is believed to represent a critical reduction of cerebral perfusion pressure, also called misery perfusion or stage II ischemia, where CBF reduction and residual oxygen consumption cause a relative elevation of OEF in the brain. The detection of misery perfusion (elevated OEF) is important in assessing the necessities of neurosurgical treatments, including extracranial–intracranial bypass surgery, due to high rates of ischemic events and recurrent strokes. Cerebrovascular reactivity (CVR) is also measured as a risk indicator for symptom recurrence and indication for surgery [3,4]. CVR is defined as the ability to increase CBF in response to vasodilatory stimuli, and a low CVR is associated with higher ischemic stroke risk. The acetazolamide (ACZ) challenge test is widely used to measure CVR in brain PET [5,6].
Arterial spin labeling (ASL) is a magnetic resonance (MR) perfusion assessment method that uses magnetically labeled arterial blood as an endogenous tracer without exposure to radiation [7,8,9]. Recently reported CBF measurements often employ the ASL method [10,11]. Quantitative CBF measurement by ASL requires quantified parameters such as the T1 value of brain tissue, T1 value of arterial blood, arterial blood volume, and, the most important parameter, arterial transit time (ATT) [12]. ATT is the time required for the labeled spins to reach brain tissue from the labeled surface and varies widely with pathology, age, and vascular region. In regions with prolonged ATT, the label effect is smaller due to T1 relaxation of the inverted spin. Therefore, for quantitative CBF evaluation in steno-occlusive CVDs using ASL, it is necessary to account for the label effect reduction associated with ATT prolongation (ATT correction).
Moyamoya disease (MMD) is a chronic steno-occlusive CVD that causes chronic progressive stenosis of internal carotid artery (ICA) endings and abnormal vascular network formation (Moyamoya vessels) in the cerebral basal region as collateral blood flow [13,14], where slow blood flow through collateral blood vessels results in label effect reduction and CBF underestimation due to ATT prolongation in MR-ASL examinations [15,16]. ASL images consisting of multiple postlabeling delays (PLDs) are used to obtain an accurate ATT map [17]. However, acquiring multiple PLD images is difficult in routine clinical examinations due to the long acquisition time [16]. Recently, the Hadamard Multidelay method was devised to improve time efficiency [18]; thus, protocols with clinically applicable scan time were proposed [19].
According to classic basic hemodynamic autoregulation theory, in normal brain perfusion areas with well-preserved CVR, ACZ loading causes peripheral vessels to dilate and vascular resistance to decrease [20]. Decreased vascular resistance is expected to result in faster tissue passage and consequently shorter ATT. In contrast, in areas where the main artery is stenotic or obstructed with collateral pathways, increased vascular resistance is expected to result in slower tissue passage and consequently prolonged ATT. In addition, in the state of misery perfusion, vasodilation by autoregulation has already occurred, and the reactivity to ACZ loading is expected to be reduced.
Based on the above, we hypothesized that ATT correction using multiple PLD images may increase the accuracy of ASL-CBF measurements before and after ACZ loading and that ASL-ATT may be a hemodynamic parameter and correlated with PET-CVR [21,22]. The aim of this study was to assess the association of ASL parameters with 15O-water PET-CBF before and after ACZ loading and PET-CVR in MMD simultaneously obtained by integrated PET/MRI.

2. Materials and Methods

2.1. Patients

This study was approved by the Ethics Committee of University of Fukui, Faculty of Medical Sciences (study protocol # 20170214, 14 February 2017), based on its guidelines (Ethical Guidelines for Medical Science Research with Humans) as well as the Helsinki Declaration of 1975 (revised in 1983). Written informed consent was obtained from each patient. This study prospectively enrolled 12 patients (4 men and 8 women, median age 42 years, age range 11–85 years) with MMD who were undergoing PET/MR examinations with the ACZ loading test performed at our university hospital between May 2017 and February 2020. The stenosis ratio was determined according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria for cerebral and cervical vessels, a method originally used for evaluating cervical blood vessels (stenosis ratio 50–70%, moderate; 71–100%, severe). Eleven patients were measured based on digital subtraction angiography (DSA), and one patient was measured based on MR angiography (MRA) images. The clinical characteristics of the study population are summarized in Table 1.

2.2. MR Imaging

A whole-body PET/MRI scanner (Signa PET/MR, GE Healthcare, Milwaukee, WI, USA) equipped with standard 8-channel head coil was used for simultaneous PET and MRI data acquisition [23]. FSPGR (GE Healthcare) T1-weighted images (repetition time, 8.5 ms; echo time, 3.2 ms; flip angle, 12°; slice thickness, 1.4 mm; 136 slices; pixel size, 1.0 × 1.0 mm) were acquired for structural images.
All ASL imaging was acquired with a pseudocontinuous ASL sequence (pCASL) followed by 3D spiral spin echo readout without vascular crusher gradient. For robust arterial transit time and precise CBF estimation within a clinically acceptable period, we used the combined acquisition of Hadamard-encoded multidelay (He-pCASL) and long-labeled long-delay pseudocontinuous arterial spin labeling (LLLD-pCASL). The details are described in-depth by our previous paper [19], and here in brief. First, three delayed He-pCASLs produces three sub-bolus conditions and their entire bolus, four conditions in total. Second, a single-delay pCASL with a long LD of 4000 ms and long PLD of 3000 ms was also acquired. The exact numerated bolus conditions were as follows: [LD (ms), PLD (ms)] = [958, 700], [1131, 1658], [1909, 2790], [4000, 700], and [4000, 3000] for the first, second, and third sub-boluses of He-pCASL, the LLSD, and the LLLD-pCASL, respectively.

2.3. ATT and CBF Calculation on ASL

ATT was calculated using the signal-weighted delay (WD) method from the following Equations (1) and (2) [18] using the ASL signal obtained in each [LD, PLD] condition, which model the ASL signal function being converted to a monotonically increasing function for δ a :
W D δ a = i = 1 n w i · Δ M δ a , w i / i = 1 n Δ M δ a , w i
The single-compartment model was assumed for the perfusion signal in WD function.
Δ M w i M 0 = 2 α T 1 a λ · f     ·   e x p δ a T 1 a e x p m a x w i δ a , 0 T 1 a e x p m a x w i δ a + τ i , 0 T 1 a
In the above equations, ΔM is the perfusion signal, δ a is the arterial transit time, wi is the postlabeling delay of the i-th [LD, PLD] condition of ASL acquisition, M0 is the equilibrium magnetization of arterial blood, α is the labeling efficiency (0.85), λ is partition coefficient (0.9), f is cerebral blood flow, T 1 a is the longitudinal relaxation time of arterial blood (1.65 s), and τ is label duration.
Once ATT was determined by the weighted delay method, CBF with ATT correction was calculated. The details how the ATT corrected CBF in the least-squares solution using all [LD, PLD] conditions is previously reported [19]. Figure 1 demonstrates the calculation of ATT corrected ASL-CBF from five perfusion signals, four from Hadamard and the other from LLLD acquisition, in a normal subject.

2.4. PET Acquisition and CBF Calculation

Each subject received 555 MBq of 15O-water radiotracer before and 15 min after acetazolamide (ACZ) administration. The image-derived input function (IDIF) method was employed for the calculation of PET-CBF without the arterial sampling [24]. After tracer injection, the dynamic 3D PET images were reconstructed from the 3-min list mode TOF data in 21 frames of 12 × 5 s, 6 × 10 s, and 3 × 20 s, and PSF on. Decay in radioactivity of the dynamic PET data was corrected to the starting point of each scan. The dynamic PET data and MRA images were transferred to a workstation (AW4.6, GE Healthcare, Chicago, IL, USA) to obtain an arterial input function from images. Attenuation correction was achieved using the zero-TE MRI-based attenuation correction (ZTE-MRAC) [25].
PET-CBF images were calculated using the following methods: The autoradiography (ARG) method with a partition coefficient of 0.9 [24]. Time-activity curves from the IDIF were used for the arterial input function. The 3-min static PET image was used for the brain tissue count in the ARG method.

2.5. Date Analysis

We used the SPM (version 12; The Wellcome Trust Centre for Neuroimaging) for the image registration, standardization, and brain mask creation processes. Final region-of-interest (ROI) value extraction and image-display processing were performed by in-house software written in MATLAB version 2022a (The Math Works, Inc. Natick, MA, USA). First, all images of PET-CBF, ASL-CBF, and ASL-ATT before and after ACZ challenge were co-registered to the same structural whole-brain T1WI. Second, a gray matter (GM) brain mask was created from each subject T1WI by segmentation of the brain using the SPM command. Finally, each subject’s T1WI was converted to a standardized T1-weighted Montreal Neurological Institute (MNI) template in a 152–2mm space along with all CBF, ATT, GM-mask by using the built-in SPM function for rigid-body transformation.
The transit time-based ROI value extraction was used in the comparison between PET and ASL parametric images, which were categorized into 18 regions: the left and right proximal, intermediate, and distal regions of each of the major anterior cerebral artery (ACA), middle cerebral artery (MCA), and the posterior cerebral artery (PCA) territories, which is previously reported and available in MNI standard space [26]. Figure 2 shows transit time-based ROIs. Relative CBF value in each ROI was calculated relative to the whole gray mask CBF value in each PET and ASL-CBF. We selected the MCA ROIs when we compared ROIs with affected and nonaffected cerebral flow based on the PET-CVR less than mean value of 30%.

2.6. Statistical Analysis

Regression analyses were performed using Pearson’s correlation coefficient (r) between baseline absolute and relative ASL-CBF and PET-CBF, between absolute and relative ASL-CBF and PET-CBF after ACZ loading, between the changes of ASL-CBF (ΔASL-CBF) and PET-CBF (ΔPET-CBF), and between baseline ASL-ATT and ΔPET-CBF and PET-CVR (percent increase). Regression analyses were performed using all transit time-based ROIs, described in the previous section. The Pearson’s r value is considered to have almost negligible correlation when ranging 0–0.3, low correlation when 0.3–0.5, moderate correlation when 0.5–0.7, and a high correlation when it ranges 0.7–1 [27]. Differences in the ASL-ATTs and ratio between ROIs with and without CVR of MCA territory of less than 30% were assessed using the unpaired t test. All statistical analyses were performed using SPSS statistics version 22. p < 0.05 was considered significant, except that p < 0.05/3 = 0.017 (Bonferroni correction) was considered significant between baseline ASL-ATT and ΔPET-CBF and PET-CVR.

3. Results

3.1. Correlation of ASL-CBF with PET-CBF

Before ACZ loading (baseline), absolute and relative ASL-CBF were significantly correlated with absolute and relative PET-CBF, respectively (Pearson’s r = 0.44, p < 0.0001, and r = 0.55, p < 0.0001, respectively) (Figure 3a,b). After ACZ loading, absolute and relative ASL-CBF were significantly correlated with absolute and relative PET-CBF, respectively (r = 0.56, p < 0.001, and r = 0.75, p < 0.0001, respectively) (Figure 3c,d), and ΔASL-CBF was significantly correlated with ΔPET-CBF (r = 0.65, p < 0.0001) (Figure 3e).

3.2. Correlation and Comparison of Baseline ASL-ATT with PET-CBF Changes

Baseline ASL-ATT had strong negative correlations with ΔPET-CBF and PET-CVR (r = −0.72, p < 0.0001, and r = −0.66, p < 0.0001, respectively) (Figure 4a,b). Baseline ASL-ATT of MCA territories with PET-CVR less than 30% (mean ± SD = 1546 ± 379 ms) was significantly higher than that with PET-CVR more than 30% (898 ± 197 ms) (Figure 4c). ASL-ATT ratio of MCA territories with PET-CVR less than 30% (94.0 ± 10.5%) was significantly higher than that with PET-CVR more than 30% (81.4 ± 11.3%) (Figure 4d).

3.3. Representative Images

Figure 5 shows representative images of a 46-year-old woman with severe MMD (patient No. 6) with transient ischemic attack (TIA) symptoms. A T2-weighted MR image (a) shows no abnormal findings in the brain parenchyma; however, MR angiography (b) demonstrates severe stenosis of the right ICA. Despite the slight overestimation of ASL-CBF compared with PET-CBF, baseline and post-ACZ ASL-CBF with ATT correction (c,d) are similar to baseline and post-ACZ PET-CBF (e,f), respectively. Baseline ASL-ATT was prolonged in the right MCA territory (g). Although the prolonged ASL-ATT in the right MCA territory remained about the same even after ACZ loading, post-ACZ ASL-ATT was shortened in the left MCA territory due to the decreased vascular resistance (h). Decreases in ΔPET-CBF and PET-CVR in the right MCA territory (i,j, respectively) were similar to a negative/positive inversion of prolonged ASL-ATT.

4. Discussion

The present study demonstrated two benefits of ASL-ATT measurements for evaluating ASL-CBF in MMD patients with chronic severe stenosis or occlusion of ICA endings and formation of Moyamoya vessels. Firstly, ATT correction using multiple PLD images compensated for the label effect reduction and underestimation of ASL-CBF and increased the accuracy of ASL-CBF quantitation both before and after ACZ loading. Secondly, baseline ASL-ATT was significantly and negatively correlated with PET-CVR measured using the ACZ challenge and may present an efficient alternative.
CVR is important in chronic steno-occlusive CVDs for assessing risks of symptom recurrence and surgery indications. Patients with reduced CVR reportedly have a significantly higher risk of recurrent stroke compared to patients with normal CVR [3,4]. However, previous studies reported that when a threshold determined by only CVR was applied for misery perfusion detection, approximately half of the patients with reduced CVR were identified as false positives [28,29,30]. Okazawa et al. demonstrated that when the reduction in baseline CBF and CVR were combined, specificity of detection of misery perfusion improved as compared with using CVR alone [31].
Although an ASL-ATT map calculated using multiple PLD images was originally used for correcting ASL-CBF values, the present results suggested that ASL-ATT may also be used as a hemodynamic parameter, i.e., a substitute for PET-CVR [32]. Areas where major vessels are stenotic/obstructed have already undergone vasodilation by compensatory mechanisms resulting in decreased PET-CVR. In these areas, collateral vessels such as Moyamoya vessels develop but are too weak to maintain native perfusion and can be causes of prolonged ASL-ATT. In contrast, in normal areas, PET-CVR is preserved, and ACZ loading leads to a decrease in vascular resistance due to vasodilation, resulting in ASL-ATT shortening. The combined use of baseline ASL-CBF and ASL-ATT may be comparable to PET-CBF and PET-CVR measurements in detecting misery perfusion and predicting the risk of symptom recurrence in MMD patients.
ASL-CBF measurements combined with ASL-ATT have comparative advantages over PET-CBF and PET-CVR measurements. The use of baseline ASL parameters without ACZ loading is less invasive and more patient-friendly, requiring only ASL images consisting of multiple PLDs compared to using 15O-water PET with ACZ challenge to obtain baseline and post-ACZ PET-CBF and PET-CVR. Baseline ASL-CBF and ASL-ATT measurements do not require the PET cyclotron and radiopharmacy facility and can avoid radiation exposure and the adverse effects of intravenous ACZ administration. The adverse effects include headache, nausea, dizziness, tinnitus, numbness of the extremities, motor weakness of the extremities, and general malaise, especially in young females [33]. Baseline ASL-CBF and ASL-ATT measurements are safe and easy to install to evaluate misery perfusion areas in Moyamoya disease patients.
However, ASL-CBF measurements have a comparative disadvantage over PET-CBF measurements. In the present study, ASL-CBF tended to be overestimated compared to PET-CBF in hypo- and normal-perfusion areas (Figure 3). Previous studies reported that the ATT was prolonged in the affected areas of acute infarction or chronic steno-occlusive CVDs and that labeled spins were retained more in the vessels of the affected areas than in healthy areas [34,35]. This phenomenon was identified as arterial transit delay. Similar arterial transit artifacts have been reported in MMD, which in turn are reported as clinically useful signs for evaluating the presence and intensity of collateral flow [36]. In any event, Moyamoya vessels can be the sources of residual labeled spins in MMD leading to CBF measurement errors (overestimation). In addition, ACZ loading causes dilation of microvessels and increases cerebral blood volume resulting in an increase in intravascular signals, especially in the normal-perfusion areas. The measurement errors can be reduced by incorporating protocols to suppress signals in the vessels [37]. However, in the present study, we did not suppress intravascular signals to investigate the hemodynamic changes both in the affected and healthy areas as the intravascular signal suppression may offset changes in ASL-CBF before and after ACZ loading.
Study limitations include the small number of participants and the large variation of absolute ASL-CBF. Although the results demonstrate the significant correlations between ASL-CBF with ATT correction and PET-CBF and between ASL-ATT and PET-CVR in MMD patients, this method remains impractical for immediate clinical practice. Further studies with more MMD patients are necessary to confirm our preliminary results. The correlation between absolute ASL-CBF and PET-CBF was improved after ACZ loading (r = 0.56, p < 0.001), likely due to 15O-water PET reflecting intravascular tracers, which is similar to ASL-CBF measurements affected by intravascular signals; thus, the ACZ challenge may enhance the correlation between ASL-CBF and PET-CBF. Therefore, improved ASL methods for suppressing residual intravascular signals while maintaining the quantitative performance of ASL-CBF and ASL-ATT are still required [38].

5. Conclusions

In MMD, ATT correction using multiple PLD images compensated for the label effect reduction and underestimation of ASL-CBF and increased the accuracy of ASL-CBF quantitation both before and after ACZ loading. Baseline ASL-ATT was significantly and negatively correlated with PET-CVR measured using the ACZ challenge and may represent an efficient alternative to it.

Author Contributions

K.T., H.K. and H.O. conceptualized the work; K.T. and H.K. performed statistical analyses and data visualization; K.T. prepared the manuscript; H.O. and T.T. performed PET/MR scans; S.I. supervised data analysis; M.I., Y.H. and K.-I.K. contributed clinical insights; H.K., H.O. and T.T. supervised the manuscript preparation. All authors have read and agreed to the published version of the manuscript.

Funding

This study was partly funded by Grants-in-Aid for scientific research from the Japan Society for the Promotion of Science (21K07616, 21K15802).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by our hospital Institutional Ethics Committee.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

The files/data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Grubb, R.L., Jr.; Derdeyn, C.P.; Fritsch, S.M.; Carpenter, D.A.; Yundt, K.D.; Videen, T.O.; Spitznagel, E.L.; Powers, W.J. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998, 280, 1055–1060. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Yamauchi, H.; Fukuyama, H.; Nagahama, Y.; Nabatame, H.; Ueno, M.; Nishizawa, S.; Konishi, J.; Shio, H. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J. Nucl. Med. 1999, 40, 1992–1998. [Google Scholar]
  3. Derdeyn, C.P.; Grubb, R.L., Jr.; Powers, W.J. Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk. Neurology 1999, 53, 251–259. [Google Scholar] [CrossRef]
  4. Gupta, A.; Chazen, J.L.; Hartman, M.; Delgado, D.; Anumula, N.; Shao, H.; Mazumdar, M.; Segal, A.Z.; Kamel, H.; Leifer, D.; et al. Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: A systematic review and meta-analysis. Stroke 2012, 43, 2884–2891. [Google Scholar] [CrossRef]
  5. Wintermark, M.; Sesay, M.; Barbier, E.; Borbely, K.; Dillon, W.P.; Eastwood, J.D.; Glenn, T.C.; Grandin, C.B.; Pedraza, S.; Soustiel, J.F.; et al. Comparative overview of brain perfusion imaging techniques. Stroke 2005, 36, e83–e99. [Google Scholar] [CrossRef] [Green Version]
  6. Kim, E.; Sohn, C.H.; Na, D.G.; Kim, J.E.; Chang, K.H.; Kim, J.H.; Jeon, S.J. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: A comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography. J. Comput. Assist. Tomogr. 2009, 33, 546–551. [Google Scholar] [CrossRef]
  7. Williams, D.S.; Detre, J.A.; Leigh, J.S.; Koretsky, A.P. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc. Natl. Acad. Sci. USA 1992, 89, 212–216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Detre, J.A.; Leigh, J.S.; Williams, D.S.; Koretsky, A.P. Perfusion imaging. Magn. Reson. Med. 1992, 23, 37–45. [Google Scholar] [CrossRef] [PubMed]
  9. Alsop, D.C.; Detre, J.A. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998, 208, 410–416. [Google Scholar] [CrossRef]
  10. Ye, F.Q.; Berman, K.F.; Ellmore, T.; Esposito, G.; van Horn, J.D.; Yang, Y.; Duyn, J.; Smith, A.M.; Frank, J.A.; Weinberger, D.R.; et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn. Reson. Med. 2000, 44, 450–456. [Google Scholar] [CrossRef]
  11. Fan, A.P.; Jahanian, H.; Holdsworth, S.J.; Zaharchuk, G. Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review. J. Cereb. Blood Flow Metab. 2016, 36, 842–861. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Parkes, L.M.; Tofts, P.S. Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: Accounting for capillary water permeability. Magn. Reson. Med. 2002, 48, 27–41. [Google Scholar] [CrossRef]
  13. Scott, R.M.; Smith, E.R. Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 2009, 360, 1226–1237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Gupta, A.; Tyagi, A.; Romo, M.; Amoroso, K.C.; Sonia, F. Moyamoya Disease: A Review of Current Literature. Cureus 2020, 12, e10141. [Google Scholar] [CrossRef] [PubMed]
  15. Kimura, H.; Kado, H.; Koshimoto, Y.; Tsuchida, T.; Yonekura, Y.; Itoh, H. Multislice continuous arterial spin-labeled perfusion MRI in patients with chronic occlusive cerebrovascular disease: A correlative study with CO2 PET validation. J. Magn. Reason. Imaging 2005, 22, 189–198. [Google Scholar] [CrossRef] [PubMed]
  16. Tsujikawa, T.; Kimura, H.; Matsuda, T.; Fujiwara, Y.; Isozaki, M.; Kikuta, K.; Okazawa, H. Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease. PLoS ONE 2016, 11, e0156005. [Google Scholar] [CrossRef] [Green Version]
  17. Kamano, H.; Yoshiura, T.; Hiwatashi, A.; Abe, K.; Togao, O.; Yamashita, K.; Honda, H. Arterial spin labeling in patients with chronic cerebral artery steno-occlusive disease: Correlation with 15O-PET. Acta Radiol. 2013, 54, 99–106. [Google Scholar] [CrossRef]
  18. Dai, W.; Robson, P.M.; Shankaranarayanan, A.; Alsop, D.C. Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn. Reson. Med. 2012, 67, 1252–1265. [Google Scholar] [CrossRef] [Green Version]
  19. Ishida, S.; Kimura, H.; Isozaki, M.; Takei, N.; Fujiwara, Y.; Kanamoto, M.; Kosaka, N.; Matsuda, T.; Kidoya, E. Robust arterial transit time and cerebral blood flow estimation using combined acquisition of Hadamard-encoded multi-delay and long-labeled long-delay pseudo-continuous arterial spin labeling: A simulation and in vivo study. NMR Biomed. 2020, 33, e4319. [Google Scholar] [CrossRef]
  20. Powers, W.J.; Press, G.A.; Grubb, R.L., Jr.; Gado, M.; Raichle, M.E. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann. Intern. Med. 1987, 106, 27–34. [Google Scholar] [CrossRef] [Green Version]
  21. Mangla, R.; Kolar, B.; Almast, J.; Ekholm, S.E. Border zone infarcts: Pathophysiologic and imaging characteristics. Radiographics 2011, 31, 1201–1214. [Google Scholar] [CrossRef]
  22. Hendrikse, J.; Petersen, E.T.; van Laar, P.J.; Golay, X. Cerebral border zones between distal end branches of intracranial arteries: MR imaging. Radiology 2008, 246, 572–580. [Google Scholar] [CrossRef] [PubMed]
  23. Levin, C.S.; Maramraju, S.H.; Khalighi, M.M.; Deller, T.W.; Delso, G.; Jansen, F. Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System. IEEE Trans. Med. Imaging 2016, 35, 1907–1914. [Google Scholar] [CrossRef]
  24. Okazawa, H.; Higashino, Y.; Tsujikawa, T.; Arishima, H.; Mori, T.; Kiyono, Y.; Kimura, H.; Kikuta, K.I. Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation. Eur. J. Radiol. 2018, 105, 102–109. [Google Scholar] [CrossRef]
  25. Okazawa, H.; Tsujikawa, T.; Higashino, Y.; Kikuta, K.I.; Mori, T.; Makino, A.; Kiyono, Y. No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction. EJNMMI Res. 2019, 9, 26. [Google Scholar] [CrossRef] [Green Version]
  26. Mutsaerts, H.J.; van Dalen, J.W.; Heijtel, D.F.; Groot, P.F.; Majoie, C.B.; Petersen, E.T.; Richard, E.; Nederveen, A.J. Cerebral Perfusion Measurements in Elderly with Hypertension Using Arterial Spin Labeling. PLoS ONE 2015, 10, e0133717. [Google Scholar] [CrossRef]
  27. Mukaka, M.M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 2012, 24, 69–71. [Google Scholar] [PubMed]
  28. Okazawa, H.; Yamauchi, H.; Toyoda, H.; Sugimoto, K.; Fujibayashi, Y.; Yonekura, Y. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: A PET study with the acetazolamide test in cerebrovascular disease. J. Nucl. Med. 2003, 44, 1875–1883. [Google Scholar] [PubMed]
  29. Yamauchi, H.; Okazawa, H.; Kishibe, Y.; Sugimoto, K.; Takahashi, M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J. Neurol. Neurosurg. Psychiatry 2004, 75, 33–37. [Google Scholar]
  30. Nemoto, E.M.; Yonas, H.; Kuwabara, H.; Pindzola, R.R.; Sashin, D.; Meltzer, C.C.; Price, J.C.; Chang, Y.; Johnson, D.W. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J. Cereb. Blood Flow Metab. 2004, 24, 1081–1089. [Google Scholar] [CrossRef]
  31. Okazawa, H.; Tsuchida, T.; Kobayashi, M.; Arai, Y.; Pagani, M.; Isozaki, M.; Yonekura, Y. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity? Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 121–129. [Google Scholar] [CrossRef]
  32. Takeuchi, K.; Isozaki, M.; Higashino, Y.; Kosaka, N.; Kikuta, K.I.; Ishida, S.; Kanamoto, M.; Takei, N.; Okazawa, H.; Kimura, H. The Utility of Arterial Transit Time Measurement for Evaluating the Hemodynamic Perfusion State of Patients with Chronic Cerebrovascular Stenosis or Occlusive Disease: Correlative Study between MR Imaging and 15O-labeled H2O Positron Emission Tomography. Magn. Reson. Med. Sci. 2022. [Google Scholar] [CrossRef]
  33. Saito, H.; Ogasawara, K.; Suzuki, T.; Kuroda, H.; Kobayashi, M.; Yoshida, K.; Kubo, Y.; Ogawa, A. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. Neurol. Med. Chir. 2011, 51, 479–483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Detre, J.A.; Alsop, D.C.; Vives, L.R.; Maccotta, L.; Teener, J.W.; Raps, E.C. Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease. Neurology 1998, 50, 633–641. [Google Scholar] [CrossRef]
  35. Chalela, J.A.; Alsop, D.C.; Gonzalez-Atavales, J.B.; Maldjian, J.A.; Kasner, S.E.; Detre, J.A. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000, 31, 680–687. [Google Scholar] [CrossRef]
  36. Zaharchuk, G.; Do, H.M.; Marks, M.P.; Rosenberg, J.; Moseley, M.E.; Steinberg, G.K. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke 2011, 42, 2485–2491. [Google Scholar] [CrossRef] [Green Version]
  37. Ye, F.Q.; Mattay, V.S.; Jezzard, P.; Frank, J.A.; Weinberger, D.R.; McLaughlin, A.C. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn. Reson. Med. 1997, 37, 226–235. [Google Scholar] [CrossRef] [PubMed]
  38. Amemiya, S.; Watanabe, Y.; Takei, N.; Ueyama, T.; Miyawaki, S.; Koizumi, S.; Kato, S.; Takao, H.; Abe, O.; Saito, N. Arterial Transit Time-Based Multidelay Combination Strategy Improves Arterial Spin Labeling Cerebral Blood Flow Measurement Accuracy in Severe Steno-Occlusive Diseases. J. Magn. Reason. Imaging 2022, 55, 178–187. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The calculation of ATT corrected ASL-CBF using the combined Hadamard and long-labeled long-delay (LLLD) acquisitions. (a) Perfusion signal (ΔM/M0) map of [LD, PLD] = [1.33, 0.7], (b) ΔM/M0 map of [LD, PLD] = [1.33, 2.03], (c) ΔM/M0 map of [LD, PLD] = [1.33, 3.36], (d) ΔM/M0 map of [LD, PLD] = [4.0, 0.7], (e) ΔM/M0 map of [LD, PLD] = [4.0, 3.0], (f) ATT-corrected CBF, (g) ATT map, (h) plots of each ΔM/M0 and the draw of selected least square solution. Plotted points are in left cerebral cortical pixel in the central semiovale section of the maps of (ae), respectively.
Figure 1. The calculation of ATT corrected ASL-CBF using the combined Hadamard and long-labeled long-delay (LLLD) acquisitions. (a) Perfusion signal (ΔM/M0) map of [LD, PLD] = [1.33, 0.7], (b) ΔM/M0 map of [LD, PLD] = [1.33, 2.03], (c) ΔM/M0 map of [LD, PLD] = [1.33, 3.36], (d) ΔM/M0 map of [LD, PLD] = [4.0, 0.7], (e) ΔM/M0 map of [LD, PLD] = [4.0, 3.0], (f) ATT-corrected CBF, (g) ATT map, (h) plots of each ΔM/M0 and the draw of selected least square solution. Plotted points are in left cerebral cortical pixel in the central semiovale section of the maps of (ae), respectively.
Diagnostics 13 00756 g001
Figure 2. The regions of interest (ROI) were placed proximal, middle, and distal to the major vascular territories with structures located in the deep gray matter not included (e.g., basal ganglia and thalamus); 18 regions were measured per case. ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery.
Figure 2. The regions of interest (ROI) were placed proximal, middle, and distal to the major vascular territories with structures located in the deep gray matter not included (e.g., basal ganglia and thalamus); 18 regions were measured per case. ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery.
Diagnostics 13 00756 g002
Figure 3. Correlation between PET-CBF and ASL-CBF. (a) Pre-ACZ absolute PET-CBF and ASL-CBF, (b) pre-ACZ relative PET-CBF and ASL-CBF, (c) post-ACZ absolute PET-CBF and ASL-CBF, (d) post-ACZ relative PET-CBF and ASL-CBF, (e) differences in ASL-CBF (ΔASL-CBF) and PET-CBF (ΔPET-CBF) between baseline and post-ACZ states. Regression lines are shown with Pearson’s correlation coefficients (r) and associated p-values.
Figure 3. Correlation between PET-CBF and ASL-CBF. (a) Pre-ACZ absolute PET-CBF and ASL-CBF, (b) pre-ACZ relative PET-CBF and ASL-CBF, (c) post-ACZ absolute PET-CBF and ASL-CBF, (d) post-ACZ relative PET-CBF and ASL-CBF, (e) differences in ASL-CBF (ΔASL-CBF) and PET-CBF (ΔPET-CBF) between baseline and post-ACZ states. Regression lines are shown with Pearson’s correlation coefficients (r) and associated p-values.
Diagnostics 13 00756 g003aDiagnostics 13 00756 g003b
Figure 4. Correlation between pre-ACZ ASL-ATT and ΔPET-CBF (a) and CVR (b). Regression lines are shown with Pearson’s correlation coefficients (r) and associated p-values. Group comparisons of ASL-ATTs (c) and the ratio (d) between ROIs with and without CVR of MCA territory less than 30%. The significance of differences was assessed by unpaired t test.
Figure 4. Correlation between pre-ACZ ASL-ATT and ΔPET-CBF (a) and CVR (b). Regression lines are shown with Pearson’s correlation coefficients (r) and associated p-values. Group comparisons of ASL-ATTs (c) and the ratio (d) between ROIs with and without CVR of MCA territory less than 30%. The significance of differences was assessed by unpaired t test.
Diagnostics 13 00756 g004
Figure 5. Representative images of a 46-year-old woman with severe Moyamoya disease (patient No. 6). T2-weighted MR image (a), MR angiography (b), baseline ASL-CBF (c), post-ACZ ASL-CBF (d), baseline PET-CBF (e), post-ACZ PET/CBF (f), baseline ASL-ATT (g), post-ACZ ASL-ATT (h), ΔPET-CBF (i), and CVR (j) CVR; cerebrovascular reactivity.
Figure 5. Representative images of a 46-year-old woman with severe Moyamoya disease (patient No. 6). T2-weighted MR image (a), MR angiography (b), baseline ASL-CBF (c), post-ACZ ASL-CBF (d), baseline PET-CBF (e), post-ACZ PET/CBF (f), baseline ASL-ATT (g), post-ACZ ASL-ATT (h), ΔPET-CBF (i), and CVR (j) CVR; cerebrovascular reactivity.
Diagnostics 13 00756 g005aDiagnostics 13 00756 g005b
Table 1. Patient characteristics and clinical data.
Table 1. Patient characteristics and clinical data.
Patient AgeSexStenosis/OcclusionSeveritySymptom
144FR MCAsevereasymptomatic
285ML ICAseverehemiparesis
344FR ICA, MCA, A1. L ICA topseverehemiparesis
438FR ICA top, MCA, A1severehemiparesis
551MR ICA, MCA. R/L ACAseverehemiparesis, dysarthria
646FR ICA top, MCA, A1severeTIA
746MR ICA top, MCA, A1severecerebral hemorrhage
845FR/L ICA top, MCAseverehigher brain dysfunction
942FR/L ICA topsevereTIA
1042MR ICA top, MCAsevereasymptomatic
1115FR/L ICA top, MCAsevereheadache
1211FR/L ICA top, MCAsevereheadache
The stenosis ratio was determined according to the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria for cerebral and cervical vessels, a method originally used for evaluating cervical blood vessels (stenosis ratio 50–70%, moderate; 71–100%, severe). Note: male (M); female (F); right (R); left (L); middle cerebral artery (MCA); anterior cerebral artery (ACA); internal carotid artery (ICA); first segment of anterior cerebral artery (A1); transient ischemic attack (TIA).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Takata, K.; Kimura, H.; Ishida, S.; Isozaki, M.; Higashino, Y.; Kikuta, K.-I.; Okazawa, H.; Tsujikawa, T. Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI. Diagnostics 2023, 13, 756. https://doi.org/10.3390/diagnostics13040756

AMA Style

Takata K, Kimura H, Ishida S, Isozaki M, Higashino Y, Kikuta K-I, Okazawa H, Tsujikawa T. Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI. Diagnostics. 2023; 13(4):756. https://doi.org/10.3390/diagnostics13040756

Chicago/Turabian Style

Takata, Kenji, Hirohiko Kimura, Shota Ishida, Makoto Isozaki, Yoshifumi Higashino, Ken-Ichiro Kikuta, Hidehiko Okazawa, and Tetsuya Tsujikawa. 2023. "Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI" Diagnostics 13, no. 4: 756. https://doi.org/10.3390/diagnostics13040756

APA Style

Takata, K., Kimura, H., Ishida, S., Isozaki, M., Higashino, Y., Kikuta, K. -I., Okazawa, H., & Tsujikawa, T. (2023). Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI. Diagnostics, 13(4), 756. https://doi.org/10.3390/diagnostics13040756

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop